Hualan Biological Vaccine Inc. (301207.SZ)

18.19 +0.72 (+4.12%) At close: 03:04PM CST

Hualan Biological Vaccine Inc.

No. 1-A-1, Hualan Avenue
Xinxiang 453003
China
86 37 3355 9991
https://www.hualanbacterin.com

Sector(s): Healthcare
Industry: Biotechnology
Full-time employees: 770

Key executives

Name	Title	Pay	Exercised	Year born
Ms. Wenjue An	GM & Director	N/A	N/A	1989
Ms. Ruowen Pan	Deputy GM & Director	N/A	N/A	1968

Amounts are as of , and compensation values are for the last fiscal year ending on that date. Pay includes salary, bonuses, etc. Exercised is the value of options exercised during the fiscal year. Currency in CNY.

Description

Hualan Biological Bacterin Inc. engages in the research, development, production, and sale of vaccines in China. It offers influenza virus split vaccines, quadrivalent influenza virus split vaccines, H1N1 influenza virus split vaccines, ACYW135 meningococcal polysaccharide plague vaccines, recombinant hepatitis B vaccines, and group A and C meningococcal polysaccharide vaccines, as well as genetic engineering vaccines for human use. The company was founded in 2005 and is based in Xinxiang, China.

Corporate governance

Hualan Biological Vaccine Inc.’s ISS governance QualityScore as of N/A is N/A. The pillar scores are Audit: N/A; Board: N/A; Shareholder rights: N/A; Compensation: N/A.

Corporate governance scores courtesy of Institutional Shareholder Services (ISS). Scores indicate decile rank relative to index or region. A decile score of 1 indicates lower governance risk, while 10 indicates higher governance risk.